Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Epitel
AddedFeb 15, 2024
UpdatedJun 18, 2026
Epitel

Epitel

Series A

Epilog, based in Salt Lake City, US, provides a wearable seizure detection system for effective epilepsy management.

HQ
Salt Lake City, UT, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Epitel, based in Salt Lake City, US, was founded with the mission to revolutionize epilepsy management through innovative technology. The company's core product, REMI™, is a groundbreaking, wireless wearable seizure detection system that records long-term EEG data, providing individuals with epilepsy a reliable tool to monitor and manage their condition effectively. By leveraging advanced AI for event detection, Epitel aims to offer peace of mind and enhance the quality of life for people living with epilepsy.

Notable affiliated individuals and investors include leading neurologists and technology experts who have contributed to the development and refinement of the REMI™ system. Epitel has achieved significant milestones, including FDA clearance for its device and successful deployment in both healthcare facilities and ambulatory settings. The overall impact of Epitel's technology is profound, offering unprecedented accuracy and convenience in seizure monitoring, thereby empowering patients and healthcare providers with critical insights for better epilepsy management.

Epitel - Quick Facts

When was Epitel founded?

Epitel was founded in 2017.

Where is Epitel's headquarters located?

Epitel's headquarters is located in Salt Lake City, UT, US.

When was Epitel's last funding round?

Epitel's most recent funding round was for $12.5M (USD) in February 2022.

How much has Epitel raised to-date?

As of Feb 16, 2022, Epitel has raised a total of $20.4M (USD).

How many employees does Epitel have?

Epitel has 37 employees as of Feb 4, 2024.

Epitel - Classification

Industry
  • Hardware
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Seizure Detection
Tags
  • Healthcare
  • Healthtech
  • Medical Device
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 7 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software